drugset / Trial / NCT04435574

Lactoferrin for Treatment of Iron Deficiency Anemia.

NCT04435574

Phase 4 Completed 90 enrolled Cairo University
RandomizedSingle-groupOpen-labelTreatment

Summary

Anemia is a great public health problem affecting both developing and developed countries. Iron deficiency anemia represents about 50% of causes of anemia worldwide. Lactoferrin fortified milk has a positive effect on Hb and iron status of infants. the hypothesis of this study is "lactoferrin may have comparable efficacy to ferrous sulfate therapy with more tolerability and fewer side effects". the research question of this study is whether oral lactoferrin is effective for treatment of iron deficiency anemia, compared to traditional ferrous sulfate therapy regarding hemoglobin rise and side effects and tolerability.

Timeline

Start
2018-09-05
Primary completion
2019-04-01
Completion
2019-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferrous Sulfate Diagnostic / imaging agent 6 mg/kg
Subject Lactoferrin Protein / enzyme biologic 100 mg Oral